A Comparison of Hepatopathologists' and Community Pathologists' Review of Liver Biopsy Specimens From Patients With Hepatitis C

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 3, 2009, Pages 335-338

  Robert, Maire ^a   Sofair, Andre N ^a   Thomas, Ann ^b   Bell, Beth ^c   Bialek, Stephanie ^c   Corless, Christopher ^d   Ness, Grace Van ^b   Huie White, Sharon ^a   Stabach, Nicole ^a   Zaman, Atif ^d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OREGON PUBLIC HEALTH DIVISION   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMMUNITY PATHOLOGIST; GOLD STANDARD; HEPATITIS C; HEPATOPATHOLOGIST; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; MEASUREMENT ERROR; MEDICAL SPECIALIST; PATHOLOGIST; TISSUE FIXATION;

BIOPSY; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; OBSERVER VARIATION; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

EID: 60949113028     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.11.029     Document Type: Article

References (20)

1. Seeff L.B., and Hoofnagle J.H. National Institutes of Health consensus development conference statement: management of hepatitis C: 2002-June 10-12, 2002. Hepatology 36 (2002) S1-S20
2. Manns M.P., McHutchison J., Gordon S.C., et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C; a randomised controlled trial. Lancet 358 (2001) 958-965
3. Fried M.W., Shirrman M.L., Reddy K.R., et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347 (2002) 975-982
4. Hadziyannis S., Sette H., Morgan T.R., et al. Peginterferon alfa-2a and ribavirin combination therapy in chronic hepatitis C. Ann Intern Med 140 (2004) 346-355
5. Holund B., Poulsen H., and Schlichting P. Reproducibility of liver biopsy diagnosis in relation to the size of the specimen. Scand J Gastroenterol 15 (1980) 329-335
6. Schlichting P., Holund B., and Poulsen H. Liver biopsy in chronic aggressive hepatitis. Diagnostic reproducibility in relation to size of specimen. Scand J Gastroenterol 18 (1983) 27-32
7. Regev A., Berho M., Jeffers L.J., et al. Sampling error and interobserver variation in liver biopsy in patients with chronic hepatitis C. Am J Gastroenterol 97 (2002) 2614-2618
8. Knodell R.G., Ishak K.G., Black W.C., et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1 (1981) 431-435
9. The French Metavir Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20 (1994) 15-20
10. Goldin R.D., Goldin J.G., Burt A.D., et al. Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis. J Hepatol 25 (1996) 649-654
11. Gronbaek K., Christensen P.B., Hamilton-Dutoit S., et al. Interobserver variation in interpretation of serial liver biopsies from patients with chronic hepatitis C. J Viral Hepat 9 (2002) 443-449
12. Bell B.P., Navarro V.J., Manos M.M., et al. The epidemiology of newly-diagnosed chronic liver disease in the United States: findings of population-based sentinel surveillance (abstr). Hepatology 34 (2001) 468A
13. Ludwig J. The nomenclature of chronic active hepatitis: an obituary. Gastroenterology 105 (1993) 274-278
14. Fleiss J.L. The measurement of interrater agreement. Statistical methods for rates and proportions (1981), Wiley, New York 212-236
15. Bruguera M., Bordas J.M., Mas P., et al. A comparison of the accuracy of peritoneoscopy and liver biopsy in the diagnosis of cirrhosis. Gut 15 (1974) 799-800
16. Pagliaro L., Rinaldi F., Craxi A., et al. Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective, randomized trial. Dig Dis Sci 28 (1983) 39-43
17. Maharaj B., Maharaj R.J., Leary W.P., et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1 (1986) 523-525
18. Abdi W., Millan J.C., and Mezey E. Sampling variability on percutaneous liver biopsy. Arch Intern Med 139 (1979) 667-669
19. Westin J., Lagging L.M., Wejstal R., et al. Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver 19 (1999) 183-187
20. Rousselet M., Michalak S., Dupré F., et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 41 (2005) 257-264